| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 1178.7 | 1050.9 | 1051.3 |
| Other income | 9.3 | 9.5 | 8.4 |
| Total income | 1188.0 | 1060.4 | 1059.6 |
| Profit before exceptional items & tax | 111.7 | 78.5 | 101.8 |
| Exceptional items | 0.0 | -13.0 | 0.0 |
| Profit before tax | 111.7 | 65.4 | 101.8 |
| Net profit | 86.4 | 46.9 | 74.0 |
| Operating margin | 9.4% | 6.2% | 9.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +16.80% |
|---|---|
| Net profit, quarter on quarter | +84.20% |
| Revenue, year on year | +12.10% |
NSE results filing, NSE: JUBLINGREA. Figures extracted from the filing.
Jubilant Ingrevia Ltd: key numbers
- Share price
- ₹656.10
- Market cap
- ₹10,450 Cr
- Revenue (annual)
- ₹4,388 Cr
- Net profit (annual)
- ₹277.9 Cr
- P/E (TTM)
- 33.9×Sector 37.5×
- Promoter holding
- 45.22%+0.00% QoQ
- FII holding
- 6.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jubilant Ingrevia Ltd
All →Jubilant Ingrevia Debt & Borrowing: ₹100 Cr
Jubilant Ingrevia has issued Commercial Papers worth Rs. 100 Crore. This issuance, with a 90-day tenure, falls within the previously approved Rs. 600 Crore outstanding limit.
- Value
- ₹100.0 Cr
Jubilant Ingrevia Employee Stock Options
Jubilant Ingrevia Employees Welfare Trust sold 8,807 shares worth Rs.0.56 Crore. The sale was executed to facilitate the exercise of ESOP options.
- Value
- ₹0.56 Cr
Jubilant Ingrevia Capital Structure Change
Jubilant Ingrevia Employees Welfare Trust sold 2,587 equity shares worth Rs. 0.17 Crore on September 11, 2026.
- Value
- ₹0.17 Cr
Jubilant Ingrevia Employee Stock Options
Jubilant Ingrevia Employees Welfare Trust sold 5,622 equity shares for Rs. 0.38 Crore. The transfer was executed pursuant to the exercise of ESOPs.
- Value
- ₹0.38 Cr
Jubilant Ingrevia Investor Presentation: Key Takeaways
Jubilant Ingrevia reported a strong Q1 FY27 with revenue at a 15-quarter high of INR 1,300 Cr (up 25% YoY). Strategy focuses on the 'Pinnacle' journey, expanding CDMO and Specialty Chemical pipelines.
Jubilant Ingrevia Q1 FY27 Results: Net Profit ₹106 Cr, Up 41.3% YoY
Jubilant Ingrevia Ltd reported revenue from operations of ₹1,300 Cr (+25.2% YoY) and net profit of ₹106 Cr (+41.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹106 Cr · +41.3% YoY